Article

Perceptions influence pain in juvenile idiopathic arthritis

Pain beliefs in children with juvenile idiopathic arthritis (JIA) influence their longitudinal course of pain. Children who have higher pain perceptions but low disease activity levels consider themselves more disabled and damaged by their JIA and limit exercise more; these beliefs appear to be highly consistent over time.

Pain beliefs in children with juvenile idiopathic arthritis (JIA) influence their longitudinal course of pain. Children who have higher pain perceptions but low disease activity levels consider themselves more disabled and damaged by their JIA and limit exercise more; these beliefs appear to be highly consistent over time.

Thastum and Herlin asked 47 children with JIA to complete the child's version of the Survey of Pain Attitudes (with subscales of control, disability, harm, and medical cure) and a 3-week pain diary at study entry (T1) and 2 years later (T2). The children's parents completed the Childhood Health Assessment Questionnaire (CHAQ), a measure of children's functional status.

Disease-related variables measured at T1 explained 40% of the variance of pain at T2. T1 cognitive beliefs predicted an additional significant 7% of the variance in T2 pain scores after controlling for T1 pain, CHAQ score, and disease activity. At T2, the high-pain group had substantially different health belief scores concerning disability and harm than the other children.

The authors noted that assessment of pain-specific beliefs and other psychological factors associated with pain may be useful in treatment of children with JIA and in identifying children who may benefit from behavioral intervention.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.